Saturday, March 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

NCDC to Conduct Biosurveillance Studies of CCHFV and Hantaviruses

by Global Biodefense Staff
December 8, 2016
Notable Biotechnology Contracts

Notable Biotechnology ContractsThe U.S. Army Medical Research Acquisition Activity (USAMRAA) has announced intentions to issue a single source award to Georgia’s National Center for Disease Control and Public Health (NCDC) to assess the seroprevalence and genetic diversity of highly pathogenic bunyaviruses circulating in the region.

NCDC will conduct active environmental surveillance studies to provide a baseline for the potential emergence of disease caused by Crimean-Congo Hemorrhagic Fever Virus (CCHFV) and hantaviruses causing hemorrhagic fever with renal syndrome (HFRS).

Viruses present in rodent and tick samples will be genetically and antigenically characterized by gene sequencing and live virus neutralization assays and if possible, virus isolations will be attempted.

The total award amount is estimated to be $413,500 USD.

Tags: Awards

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC